TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
GNLX

Genelux Corporation

Healthcare · Biotechnology

2.50$ -3.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow GNLX
Line item 2019 2020 2021 2022 2023 2024 2025
-32.3% -11,926.5% -265,350.0% -315,850.0%
8.7% 598.8% 11,287.5% 3,050.0%
21.8% 3,061.2% 75,875.0% 73,387.5%
19.0%
-15.3% -1,930.0% 9,387.5% -13,075.0%
0.4% 602.9% 4,762.5% 13,725.0%
-0.4% -8,661.2% -101,637.5% 151,762.5%
8.8% 126.5% 0.0%
-4.3% 25,894.1% 356,325.0% 123,687.5%
-37.0% 5,306.5% -10,662.5% -40,400.0%
-32.7% -12,529.4% -270,112.5% -329,575.0%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?